Filing excerpt
The company reported GAAP net income attributable to Boston Scientific common stockholders of $582 million or $0.40 per share (EPS), compared to $755 million or $0.51 per share a year ago, and achieved adjusted EPS of $0.73 for the period, compared to $0.75 a year ago.